Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials.

Vuilleumier, Caroline; Scherbaum, Norbert; Bonnet, Udo; Roser, Patrik

Vuilleumier, Caroline; Scherbaum, Norbert; Bonnet, Udo; Roser, Patrik.

Afiliação

Vuilleumier C; Department of Psychiatry and Psychotherapy, Psychiatric Services Aargau, Academic Teaching Hospital of the University of Zurich, Windisch, Switzerland.
Scherbaum N; Department of Psychiatry and Psychotherapy, LVR-Hospital Essen, Medical Faculty, University of Duisburg Essen, Essen, Germany.
Bonnet U; Department of Psychiatry and Psychotherapy, LVR-Hospital Essen, Medical Faculty, University of Duisburg Essen, Essen, Germany.
Roser P; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Evangelisches Krankenhaus Castrop-Rauxel, Academic Teaching Hospital of the University of Duisburg-Essen, Castrop-Rauxel, Germany.

Front Psychiatry ; 13: 867878, 2022.

Article em En | MEDLINE | ID: mdl-35815028

Palavras-chave

cannabinoids; cannabis use disorder (CUD); efficacy and safety; endocannabinoid system (ECS); randomized controlled trial; treatment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google